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The review summarizes information on cyclopropane as an independent pharmacophore 
group and as a fragment for modiﬁ cation of pharmacological activity level of medicines used 
in practice. The advantages of a cyclopropane fragment over its bioisosteres are that, on the one 
hand, this fragment imposes conformational rigidity on the molecules of physiologically active 
compounds and, on the other hand, the replacement of acyclic terminal and "linker" groups 
with a cyclopropane fragment increases the metabolic stability of the target structures and 
extends the scope of their therapeutic action. 
Key words: cyclopropanes, pyrimidines, cycloaddition, heterocyclization. 
Introduction 
Compounds containing a cyclopropane fragment are 
of considerable interest for both organic chemists and 
biochemists. The three-membered saturated carbocycle is 
a structural element with a wide synthetic potential due 
to the high strain energy (~ 27.5 kcal mol–1) of an unusual 
type of carbon—carbon bonds known as "banana" bonds. 
The nature of these bonds is regarded as being intermedi-
ate between - and -bonds, due to which cyclopropane 
derivatives can be involved into various ring opening and 
ring expansion reactions, as well as into cycloaddition 
reactions.1—4 From the point of view of medical use, it 
should be noted that eight of the 200 best-selling pharma-
ceuticals in the US as of 2012 (Fig. 1) are compounds 
containing a cyclopropane fragment. 5—12 
From the given examples, it is seen that cyclopropane 
functional derivatives possess a wide range of biological 
activity. Thus, they inhibit enzymatic activity (mono amine 
oxidases,13,14 DNA gyrase,15 aldehyde dehydrogenase,16—18 
amino acid decarboxylase,19 carboxypeptidase,20—22 
histidine carboxylase,23 tyrosine aminotransferase,24,25 
spermine/spermidine-N1-acetyltransferase (SSAT),26 DNA 
polymerases of herpes simplex virus (HSV)27 and HIV,28—30 
acyl coenzyme A dehydrogenase,31 etc.), exhibit receptor 
activity (acetylcholine receptors,32,33 estrogen recep-
tors,34,35 thyroid hormone receptors,36 -aminobutyric 
acid (GABA) receptors,37 ethylene receptors,38,39 etc.), as 
well as play the role of inductors of cell apoptosis of 
malignant neoplastic cells.40 
A cyclopropane fragment can either play the role of 
a structural element of the pharmacophore or participate 
in the "decoration" of the pharmacophore group as 
a modulator of the corresponding type of biological activ-
ity. In this connection, it is necessary to focus on the bio-
logical activity of cyclopropane itself (obtained by debrom-
ination of 1,3-dibromopropane with zinc41), which is used 
in clinical practice for inhalation anesthesia.42 Its main 
advantages are the absence of irritating action on the re-
spiratory tract and rapid recovery from anesthesia. Among 
the simplest cyclopropane functional derivatives, one can 
name cyclopropane-1,1-diol (a stable hydrate of cyclopro-
panone) (1) possessing inhibitory activity against yeast 
aldehyde dehydrogenase (ALDH).16,17 Cytoplasmic and 
mitochondrial aldehyde dehydrogenases found in beef liver 
are also inactivated by cyclopropanone hydrate 1 as a result 
of covalent modiﬁ cation of the fragment of heme compos-
ing the coenzyme18 (Scheme 1). 
trans-2-Phenylcyclopropylamine (tranylcypromine, 
transamin) (2) is the ﬁ rst commercially available agent 
having a cyclopropane fragment in the molecule. The ﬁ rst 
